Otsuka Pharma gets USFDA approval for Brexpiprazole to treat Alzheimer’s agitation
Brexpiprazole was previously approved in the US to treat adults with major depressive disorder and schizophrenia
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
brexpiprazole
FDA approves new drug Rexulti to treat schizophrenia
Rexulti was shown to reduce the occurrence of symptoms of schizophrenia compared to placebo (inactive tablet)